| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |